IOVANCE BIOTHERAPEUTICS, INC. Cash Equivalents, at Carrying Value
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Cash Equivalents, at Carrying Value of $61.13 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash Equivalents, at Carrying Value $61.13M.
- 2026-03-31: Cash Equivalents, at Carrying Value $79.09M.
- 2025-12-31: Cash Equivalents, at Carrying Value $60.47M.
- 2025-09-30: Cash Equivalents, at Carrying Value $49.84M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $61.13M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $79.09M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $60.47M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $49.84M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $81.37M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $124.16M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $61.43M 10-K · filed 2026-02-24 |
| 2024-09-30 | $102.71M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $61.88M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $45.72M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $34.05M 10-K · filed 2025-02-27 |
| 2022-12-31 | $132.36M 10-K · filed 2024-02-28 |
| 2021-12-31 | $61.25M 10-K · filed 2023-02-28 |
| 2021-09-30 | $42.58M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $63.10M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $74.42M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $49.72M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $51.21M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $151.13M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $39.92M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $10.05M 10-Q · filed 2020-11-05 |
| 2018-09-30 | $26.33M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $79.93M 10-Q · filed 2018-08-07 |
| 2017-12-31 | $91.28M 10-Q · filed 2018-11-06 |
| 2016-06-30 | $90.35M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $90.22M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $90.06M 10-K · filed 2016-03-11 |
| 2015-09-30 | $99.94M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $99.78M 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |